Vimarsana
Biggest News Aggregation in the World

Exception Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exception Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exception Access Today - Breaking & Trending Today

Avicanna Completes First Commercial Export of Feminized - Vimarsana News

Avicanna Completes First Commercial Export of Feminized

This marks Avicanna’s first commercial exports of proprietary genetics in the form of feminized seeds into the Peruvian and the Argentine medical cannabis...

Avicanna Completes First Commercial Export of Feminized Cannabis Seeds from Colombia to Peru and Argentina - Vimarsana News

Avicanna Completes First Commercial Export of Feminized Cannabis Seeds from Colombia to Peru and Argentina

Avicanna Inc. a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. it has completed its first commercial exports of its proprietary genetics in the form of feminized cannabis seeds to Peru and Argentina. The characterization, ...

Exception Access Regime – cannabis products and derivatives | Dentons - Vimarsana News

Exception Access Regime – cannabis products and derivatives | Dentons

To embed, copy and paste the code into your website or blog: The National Ministry of Health issued Resolution No. 654/2021 (hereinafter referred as the “Resolution”) This Resolution approved an Exception Access Regime for products that contain cannabinoids or derivatives of the cannabis plants devoted exclusively for medicinal uses in individual treatments or in the framework of scientific research. The Resolution states the cases in which the Exception Access Regime is applicable. In case of products for individual treatments whose import is authorized by the National Food, Drug and Med...